Sutro Biopharma Capital Reinvestment Ratio
Sutro Biopharma capital reinvestment ratio. Sutro Biopharma (STRO) has a Capital Reinvestment Ratio of 0.08x as of June 2024, meaning it reinvests 0% of its operating cash flow ($9.46 Million) in capital expenditures ($756.00K). Check Sutro Biopharma total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sutro Biopharma (2018–2022)
Capital reinvestment ratio of Sutro Biopharma from 2018 to 2022. This chart tracks Sutro Biopharma's Capital Reinvestment Ratio across 2 annual periods. Also explore STRO net asset momentum to track the company's year-over-year net asset growth rate.
Sutro Biopharma Capital Reinvestment Ratio by Year (2018–2022)
Sutro Biopharma capital reinvestment ratio by year from 2018 to 2022. For the full cash flow conversion analysis, see Sutro Biopharma (STRO) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.21x | $3.55 Million | $7.86 Million | ▲ +1703.6% |
| 2018 | 0.12x | $12.68 Million | $1.56 Million | — |